Extraovular PGE2 and oxytocin-implicated uterine rupture during midtrimester termination of pregnancy

S. Lurie; Z. Hagay; R. Borenstein

doi:10.1007/BF01983211

Extraovular PGE₂ and oxytocin-implicated uterine rupture during midtrimester termination of pregnancy

S. Lurie^*, Z. Hagay, R. Borenstein

^*Corresponding author for this work

Kaplan Medical Center Israel

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

A case of uterine rupture caused by extraovular PGE₂ in a sequence with intravenous oxytocin during midtrimester termination of pregnancy is presented. It teaches us that when oxytocin is used after prostaglandins in patients having a scarred uterus, the lowest effective dose should be applied.

Original language	English
Pages (from-to)	331-333
Number of pages	3
Journal	Advances in Contraception
Volume	9
Issue number	4
DOIs	https://doi.org/10.1007/BF01983211
State	Published - Dec 1993
Externally published	Yes

Access to Document

10.1007/BF01983211

Cite this

@article{ca9aa8b0cccd4286b7836312814976d0,

title = "Extraovular PGE2 and oxytocin-implicated uterine rupture during midtrimester termination of pregnancy",

abstract = "A case of uterine rupture caused by extraovular PGE2 in a sequence with intravenous oxytocin during midtrimester termination of pregnancy is presented. It teaches us that when oxytocin is used after prostaglandins in patients having a scarred uterus, the lowest effective dose should be applied.",

author = "S. Lurie and Z. Hagay and R. Borenstein",

year = "1993",

month = dec,

doi = "10.1007/BF01983211",

language = "אנגלית",

volume = "9",

pages = "331--333",

journal = "Advances in Contraception",

issn = "0267-4874",

publisher = "Springer Verlag",

number = "4",

}

TY - JOUR

T1 - Extraovular PGE2 and oxytocin-implicated uterine rupture during midtrimester termination of pregnancy

AU - Lurie, S.

AU - Hagay, Z.

AU - Borenstein, R.

PY - 1993/12

Y1 - 1993/12

N2 - A case of uterine rupture caused by extraovular PGE2 in a sequence with intravenous oxytocin during midtrimester termination of pregnancy is presented. It teaches us that when oxytocin is used after prostaglandins in patients having a scarred uterus, the lowest effective dose should be applied.

AB - A case of uterine rupture caused by extraovular PGE2 in a sequence with intravenous oxytocin during midtrimester termination of pregnancy is presented. It teaches us that when oxytocin is used after prostaglandins in patients having a scarred uterus, the lowest effective dose should be applied.

UR - http://www.scopus.com/inward/record.url?scp=0027788326&partnerID=8YFLogxK

U2 - 10.1007/BF01983211

DO - 10.1007/BF01983211

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 8147247

AN - SCOPUS:0027788326

SN - 0267-4874

VL - 9

SP - 331

EP - 333

JO - Advances in Contraception

JF - Advances in Contraception

IS - 4

ER -

Extraovular PGE₂ and oxytocin-implicated uterine rupture during midtrimester termination of pregnancy

Abstract

Access to Document

Other files and links

Fingerprint

Cite this